T T Lah

Summary

Affiliation: University of Ljubljana
Country: Slovenia

Publications

  1. ncbi request reprint Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: comparison with cathepsin D, cathepsin L, and other clinical indicators
    T T Lah
    Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, Ljubljana, Slovenia
    Clin Cancer Res 6:578-84. 2000
  2. ncbi request reprint Invasion of ras-transformed breast epithelial cells depends on the proteolytic activity of cysteine and aspartic proteinases
    A Premzl
    Jozef Stefan Institute, Department of Biochemistry and Molecular Biology, Jamova, Ljubljana, Slovenia
    Biol Chem 382:853-7. 2001
  3. ncbi request reprint Cathepsins B and L and their inhibitors stefin B and cystatin C as markers for malignant progression of benign meningiomas
    M Trinkaus
    Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, Ljubljana, Slovenia
    Int J Biol Markers 20:50-9. 2005
  4. pmc Cysteine proteinase cathepsin H in tumours and sera of lung cancer patients: relation to prognosis and cigarette smoking
    A Schweiger
    Jozef Stefan Institute, Department of Biochemistry and Molecular Biology, Ljubljana, Slovenia
    Br J Cancer 82:782-8. 2000
  5. ncbi request reprint Comparison of expression of cathepsins B and L and MMP2 in endothelial cells and in capillary sprouting in collagen gel
    S Caserman
    Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, Ljubljana, Slovenia
    Int J Biol Markers 19:120-9. 2004
  6. ncbi request reprint Proteases in brain tumour progression
    N Levicar
    Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, Ljubljana, Slovenia
    Acta Neurochir (Wien) 145:825-38. 2003

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: comparison with cathepsin D, cathepsin L, and other clinical indicators
    T T Lah
    Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, Ljubljana, Slovenia
    Clin Cancer Res 6:578-84. 2000
    ..We conclude that CatB is useful as a prognostic indicator in lymph node-negative patients. This suggests that selective adjuvant therapy should be applied in this lower risk group of patients when high levels of CatB are determined...
  2. ncbi request reprint Invasion of ras-transformed breast epithelial cells depends on the proteolytic activity of cysteine and aspartic proteinases
    A Premzl
    Jozef Stefan Institute, Department of Biochemistry and Molecular Biology, Jamova, Ljubljana, Slovenia
    Biol Chem 382:853-7. 2001
    ..7+/-1.8%). We conclude that both cysteine and aspartic proteinase activities are needed for invasion by MCF-10A neoT cells in vitro...
  3. ncbi request reprint Cathepsins B and L and their inhibitors stefin B and cystatin C as markers for malignant progression of benign meningiomas
    M Trinkaus
    Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, Ljubljana, Slovenia
    Int J Biol Markers 20:50-9. 2005
    ..The diagnostic and prognostic value for relapse of meningioma needs to be confirmed in a larger population of patients...
  4. pmc Cysteine proteinase cathepsin H in tumours and sera of lung cancer patients: relation to prognosis and cigarette smoking
    A Schweiger
    Jozef Stefan Institute, Department of Biochemistry and Molecular Biology, Ljubljana, Slovenia
    Br J Cancer 82:782-8. 2000
    ..g. cathepsin B and cathepsin L. Variations between tissue and serum levels of Cath H indicate either reduced expression or enhanced secretion of this enzyme in lung tumours...
  5. ncbi request reprint Comparison of expression of cathepsins B and L and MMP2 in endothelial cells and in capillary sprouting in collagen gel
    S Caserman
    Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, Ljubljana, Slovenia
    Int J Biol Markers 19:120-9. 2004
    ....
  6. ncbi request reprint Proteases in brain tumour progression
    N Levicar
    Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, Ljubljana, Slovenia
    Acta Neurochir (Wien) 145:825-38. 2003
    ....